3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
12
Prostatic Neoplasms
12
Oropharyngeal Neoplasms
12
Head and Neck Neoplasms
7
Carcinoma, Squamous Cell
6
Nasopharyngeal Carcinoma
5
Esophageal Neoplasms
5
Rectal Neoplasms
4
Mouth Neoplasms
4
Laryngeal Neoplasms
4
Glioma
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Salivary Gland Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Papillomavirus Infections
2
Oligodendroglioma
2
Myelodysplastic Syndromes
2
Lymphatic Metastasis
2
Leukemia, Myeloid, Acute
2
Hypopharyngeal Neoplasms
2
Glioblastoma
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma
2
Astrocytoma
2
Anus Neoplasms
2
Virus Diseases
1
Vaginal Neoplasms
1
Interventions
Gemcitabine
6
Cisplatin
6
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Capecitabine
4
Biopsy
3
pembrolizumab
2
durvalumab
2
Trastuzumab
2
Platinum
2
Oxaliplatin
2
Leucovorin
2
Fluorouracil
2
1,2-diaminocyclohexaneplatinum II citrate
2
varlilumab
1
tucatinib
1
toripalimab
1
peposertib
1
guadecitabine
1
dehydroftorafur
1
cobimetinib
1
binimetinib
1
avelumab
1
atezolizumab
1
Tegafur
1
Taxes
1
S 1 (combination)
1
Radiotherapy, Intensity-Modulated
1
Radiation Dose Hypofractionation
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Gallbladder Neoplasms
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT02867865
2025-03-13
POLCAGB
Tata Memorial Hospital
Phase 2/3
Active not recruiting
124 enrolled